Loading…

Add-on effects of oral tocopherol supplementation to surgical varicocelectomy on the outcome of assisted reproductive technology: a single-center pilot study report

Varicocelectomy is well known to improve the pregnancy outcome of patients with clinical varicoceles in assisted reproductive technologies as well as spontaneous conception. Therefore, this study aimed to evaluate the additional effects of oral antioxidant therapy after varicocelectomy on the pregna...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in reproductive health 2024-01, Vol.5, p.1325566-1325566
Main Authors: Takeshima, Teppei, Mihara, Takahiro, Tomita, Makoto, Kuroda, Shinnosuke, Yumura, Yasushi, Ueno, Hiroe, Yamamoto, Mizuki, Murase, Mariko
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c418t-43999ec89ee5e9f67c22d6a151c27db7aff53ebef715c8e0c5ad93b2fe8fcd673
container_end_page 1325566
container_issue
container_start_page 1325566
container_title Frontiers in reproductive health
container_volume 5
creator Takeshima, Teppei
Mihara, Takahiro
Tomita, Makoto
Kuroda, Shinnosuke
Yumura, Yasushi
Ueno, Hiroe
Yamamoto, Mizuki
Murase, Mariko
description Varicocelectomy is well known to improve the pregnancy outcome of patients with clinical varicoceles in assisted reproductive technologies as well as spontaneous conception. Therefore, this study aimed to evaluate the additional effects of oral antioxidant therapy after varicocelectomy on the pregnancy outcome in the assisted reproductive technology setting. This study was a retrospective cohort study. The subjects were couples among whom the male partner had undergone varicocelectomy and was scheduled for subsequent assisted reproductive technology. Pregnancy outcomes were followed retrospectively in 62 couples with male partners who received tocopherol (antioxidant group) and 37 couples who did not (control group). The tocopherol and control groups were assigned dependent on the decision of the physician in charge and the patient's request. The clinical pregnancy rates per couple and embryo transfer, time to pregnancy, and the number of cycles during transfer to pregnancy were evaluated. No significant differences were observed in the pregnancy rate per couple (antioxidant group 70.9% vs. control group 64.9%,  = 0.55) and per embryo transfer (50.4% vs. 39.6%,  = 0.22). Regarding the time to event analyzed by adjusted restricted mean survival time, the mean time to pregnancy was significantly shorter in the antioxidant (tocopherol) group (14.2 vs. 17.4 months,  = 0.025). No significant difference was observed in the embryo transfer cycle to pregnancy (mean embryo transfer cycles: 2.6 vs. 3.0,  = 0.238). Additional oral tocopherol nicotinate as antioxidant therapy after varicocelectomy was shown to shorten the time to pregnancy. It is recommended that add-on effects be tested in more well-designed randomized controlled trials to examine whether it improves assisted reproductive outcomes.
doi_str_mv 10.3389/frph.2023.1325566
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f4b4ffe024c84d85a4006b5847734e10</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f4b4ffe024c84d85a4006b5847734e10</doaj_id><sourcerecordid>2922951721</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-43999ec89ee5e9f67c22d6a151c27db7aff53ebef715c8e0c5ad93b2fe8fcd673</originalsourceid><addsrcrecordid>eNpVks1u1DAUhSMEolXpA7BBXrKZwT9x4rBBVcVPpUpsYG059vWMqyQ32M5I8z59UBxmqNqVrXvP_a59dKrqPaNbIVT3ycd5v-WUiy0TXMqmeVVd8qYVG8GkeP3sflFdp_RAKeWKKiXl2-pCKMFUQ-Vl9Xjj3AYnAt6DzYmgJxjNQDJanPcQcSBpmecBRpiyyaFIM5ZS3AVbZAcTg0ULQxnG8UjW9h4ILtniCCvNpBRSBkcizBHdYnM4AMlg9xMOuDt-JoakMO0G2NiyAiKZw4CZpLy44zqEMb-r3ngzJLg-n1fV729ff93-2Nz__H53e3O_sTVTeVOLruvAqg5AQueb1nLuGsMks7x1fWu8lwJ68C2TVgG10rhO9NyD8tYVu66quxPXoXnQcwyjiUeNJuh_BYw7bWIOdgDt674ullFeW1U7JU1NadNLVbetqIHRwvpyYs1LP4Jb_1Z8fQF92ZnCXu_woBlVoqO0K4SPZ0LEPwukrMeQitWDmQCXpHnHeSdZy1mRspPURkwpgn_aw6he06LXtOg1LfqcljLz4fkDnyb-Z0P8Bd2ewh0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2922951721</pqid></control><display><type>article</type><title>Add-on effects of oral tocopherol supplementation to surgical varicocelectomy on the outcome of assisted reproductive technology: a single-center pilot study report</title><source>PubMed Central</source><creator>Takeshima, Teppei ; Mihara, Takahiro ; Tomita, Makoto ; Kuroda, Shinnosuke ; Yumura, Yasushi ; Ueno, Hiroe ; Yamamoto, Mizuki ; Murase, Mariko</creator><creatorcontrib>Takeshima, Teppei ; Mihara, Takahiro ; Tomita, Makoto ; Kuroda, Shinnosuke ; Yumura, Yasushi ; Ueno, Hiroe ; Yamamoto, Mizuki ; Murase, Mariko</creatorcontrib><description>Varicocelectomy is well known to improve the pregnancy outcome of patients with clinical varicoceles in assisted reproductive technologies as well as spontaneous conception. Therefore, this study aimed to evaluate the additional effects of oral antioxidant therapy after varicocelectomy on the pregnancy outcome in the assisted reproductive technology setting. This study was a retrospective cohort study. The subjects were couples among whom the male partner had undergone varicocelectomy and was scheduled for subsequent assisted reproductive technology. Pregnancy outcomes were followed retrospectively in 62 couples with male partners who received tocopherol (antioxidant group) and 37 couples who did not (control group). The tocopherol and control groups were assigned dependent on the decision of the physician in charge and the patient's request. The clinical pregnancy rates per couple and embryo transfer, time to pregnancy, and the number of cycles during transfer to pregnancy were evaluated. No significant differences were observed in the pregnancy rate per couple (antioxidant group 70.9% vs. control group 64.9%,  = 0.55) and per embryo transfer (50.4% vs. 39.6%,  = 0.22). Regarding the time to event analyzed by adjusted restricted mean survival time, the mean time to pregnancy was significantly shorter in the antioxidant (tocopherol) group (14.2 vs. 17.4 months,  = 0.025). No significant difference was observed in the embryo transfer cycle to pregnancy (mean embryo transfer cycles: 2.6 vs. 3.0,  = 0.238). Additional oral tocopherol nicotinate as antioxidant therapy after varicocelectomy was shown to shorten the time to pregnancy. It is recommended that add-on effects be tested in more well-designed randomized controlled trials to examine whether it improves assisted reproductive outcomes.</description><identifier>ISSN: 2673-3153</identifier><identifier>EISSN: 2673-3153</identifier><identifier>DOI: 10.3389/frph.2023.1325566</identifier><identifier>PMID: 38318605</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>antioxidant ; assisted reproductive technology ; oxidative stress ; Reproductive Health ; tocopherol nicotinate ; varicocele ; varicocelectomy</subject><ispartof>Frontiers in reproductive health, 2024-01, Vol.5, p.1325566-1325566</ispartof><rights>2024 Takeshima, Mihara, Tomita, Kuroda, Yumura, Ueno, Yamamoto and Murase.</rights><rights>2024 Takeshima, Mihara, Tomita, Kuroda, Yumura, Ueno, Yamamoto and Murase. 2024 Takeshima, Mihara, Tomita, Kuroda, Yumura, Ueno, Yamamoto and Murase</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c418t-43999ec89ee5e9f67c22d6a151c27db7aff53ebef715c8e0c5ad93b2fe8fcd673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839009/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839009/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38318605$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takeshima, Teppei</creatorcontrib><creatorcontrib>Mihara, Takahiro</creatorcontrib><creatorcontrib>Tomita, Makoto</creatorcontrib><creatorcontrib>Kuroda, Shinnosuke</creatorcontrib><creatorcontrib>Yumura, Yasushi</creatorcontrib><creatorcontrib>Ueno, Hiroe</creatorcontrib><creatorcontrib>Yamamoto, Mizuki</creatorcontrib><creatorcontrib>Murase, Mariko</creatorcontrib><title>Add-on effects of oral tocopherol supplementation to surgical varicocelectomy on the outcome of assisted reproductive technology: a single-center pilot study report</title><title>Frontiers in reproductive health</title><addtitle>Front Reprod Health</addtitle><description>Varicocelectomy is well known to improve the pregnancy outcome of patients with clinical varicoceles in assisted reproductive technologies as well as spontaneous conception. Therefore, this study aimed to evaluate the additional effects of oral antioxidant therapy after varicocelectomy on the pregnancy outcome in the assisted reproductive technology setting. This study was a retrospective cohort study. The subjects were couples among whom the male partner had undergone varicocelectomy and was scheduled for subsequent assisted reproductive technology. Pregnancy outcomes were followed retrospectively in 62 couples with male partners who received tocopherol (antioxidant group) and 37 couples who did not (control group). The tocopherol and control groups were assigned dependent on the decision of the physician in charge and the patient's request. The clinical pregnancy rates per couple and embryo transfer, time to pregnancy, and the number of cycles during transfer to pregnancy were evaluated. No significant differences were observed in the pregnancy rate per couple (antioxidant group 70.9% vs. control group 64.9%,  = 0.55) and per embryo transfer (50.4% vs. 39.6%,  = 0.22). Regarding the time to event analyzed by adjusted restricted mean survival time, the mean time to pregnancy was significantly shorter in the antioxidant (tocopherol) group (14.2 vs. 17.4 months,  = 0.025). No significant difference was observed in the embryo transfer cycle to pregnancy (mean embryo transfer cycles: 2.6 vs. 3.0,  = 0.238). Additional oral tocopherol nicotinate as antioxidant therapy after varicocelectomy was shown to shorten the time to pregnancy. It is recommended that add-on effects be tested in more well-designed randomized controlled trials to examine whether it improves assisted reproductive outcomes.</description><subject>antioxidant</subject><subject>assisted reproductive technology</subject><subject>oxidative stress</subject><subject>Reproductive Health</subject><subject>tocopherol nicotinate</subject><subject>varicocele</subject><subject>varicocelectomy</subject><issn>2673-3153</issn><issn>2673-3153</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVks1u1DAUhSMEolXpA7BBXrKZwT9x4rBBVcVPpUpsYG059vWMqyQ32M5I8z59UBxmqNqVrXvP_a59dKrqPaNbIVT3ycd5v-WUiy0TXMqmeVVd8qYVG8GkeP3sflFdp_RAKeWKKiXl2-pCKMFUQ-Vl9Xjj3AYnAt6DzYmgJxjNQDJanPcQcSBpmecBRpiyyaFIM5ZS3AVbZAcTg0ULQxnG8UjW9h4ILtniCCvNpBRSBkcizBHdYnM4AMlg9xMOuDt-JoakMO0G2NiyAiKZw4CZpLy44zqEMb-r3ngzJLg-n1fV729ff93-2Nz__H53e3O_sTVTeVOLruvAqg5AQueb1nLuGsMks7x1fWu8lwJ68C2TVgG10rhO9NyD8tYVu66quxPXoXnQcwyjiUeNJuh_BYw7bWIOdgDt674ullFeW1U7JU1NadNLVbetqIHRwvpyYs1LP4Jb_1Z8fQF92ZnCXu_woBlVoqO0K4SPZ0LEPwukrMeQitWDmQCXpHnHeSdZy1mRspPURkwpgn_aw6he06LXtOg1LfqcljLz4fkDnyb-Z0P8Bd2ewh0</recordid><startdate>20240122</startdate><enddate>20240122</enddate><creator>Takeshima, Teppei</creator><creator>Mihara, Takahiro</creator><creator>Tomita, Makoto</creator><creator>Kuroda, Shinnosuke</creator><creator>Yumura, Yasushi</creator><creator>Ueno, Hiroe</creator><creator>Yamamoto, Mizuki</creator><creator>Murase, Mariko</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240122</creationdate><title>Add-on effects of oral tocopherol supplementation to surgical varicocelectomy on the outcome of assisted reproductive technology: a single-center pilot study report</title><author>Takeshima, Teppei ; Mihara, Takahiro ; Tomita, Makoto ; Kuroda, Shinnosuke ; Yumura, Yasushi ; Ueno, Hiroe ; Yamamoto, Mizuki ; Murase, Mariko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-43999ec89ee5e9f67c22d6a151c27db7aff53ebef715c8e0c5ad93b2fe8fcd673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>antioxidant</topic><topic>assisted reproductive technology</topic><topic>oxidative stress</topic><topic>Reproductive Health</topic><topic>tocopherol nicotinate</topic><topic>varicocele</topic><topic>varicocelectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takeshima, Teppei</creatorcontrib><creatorcontrib>Mihara, Takahiro</creatorcontrib><creatorcontrib>Tomita, Makoto</creatorcontrib><creatorcontrib>Kuroda, Shinnosuke</creatorcontrib><creatorcontrib>Yumura, Yasushi</creatorcontrib><creatorcontrib>Ueno, Hiroe</creatorcontrib><creatorcontrib>Yamamoto, Mizuki</creatorcontrib><creatorcontrib>Murase, Mariko</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in reproductive health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takeshima, Teppei</au><au>Mihara, Takahiro</au><au>Tomita, Makoto</au><au>Kuroda, Shinnosuke</au><au>Yumura, Yasushi</au><au>Ueno, Hiroe</au><au>Yamamoto, Mizuki</au><au>Murase, Mariko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Add-on effects of oral tocopherol supplementation to surgical varicocelectomy on the outcome of assisted reproductive technology: a single-center pilot study report</atitle><jtitle>Frontiers in reproductive health</jtitle><addtitle>Front Reprod Health</addtitle><date>2024-01-22</date><risdate>2024</risdate><volume>5</volume><spage>1325566</spage><epage>1325566</epage><pages>1325566-1325566</pages><issn>2673-3153</issn><eissn>2673-3153</eissn><abstract>Varicocelectomy is well known to improve the pregnancy outcome of patients with clinical varicoceles in assisted reproductive technologies as well as spontaneous conception. Therefore, this study aimed to evaluate the additional effects of oral antioxidant therapy after varicocelectomy on the pregnancy outcome in the assisted reproductive technology setting. This study was a retrospective cohort study. The subjects were couples among whom the male partner had undergone varicocelectomy and was scheduled for subsequent assisted reproductive technology. Pregnancy outcomes were followed retrospectively in 62 couples with male partners who received tocopherol (antioxidant group) and 37 couples who did not (control group). The tocopherol and control groups were assigned dependent on the decision of the physician in charge and the patient's request. The clinical pregnancy rates per couple and embryo transfer, time to pregnancy, and the number of cycles during transfer to pregnancy were evaluated. No significant differences were observed in the pregnancy rate per couple (antioxidant group 70.9% vs. control group 64.9%,  = 0.55) and per embryo transfer (50.4% vs. 39.6%,  = 0.22). Regarding the time to event analyzed by adjusted restricted mean survival time, the mean time to pregnancy was significantly shorter in the antioxidant (tocopherol) group (14.2 vs. 17.4 months,  = 0.025). No significant difference was observed in the embryo transfer cycle to pregnancy (mean embryo transfer cycles: 2.6 vs. 3.0,  = 0.238). Additional oral tocopherol nicotinate as antioxidant therapy after varicocelectomy was shown to shorten the time to pregnancy. It is recommended that add-on effects be tested in more well-designed randomized controlled trials to examine whether it improves assisted reproductive outcomes.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>38318605</pmid><doi>10.3389/frph.2023.1325566</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2673-3153
ispartof Frontiers in reproductive health, 2024-01, Vol.5, p.1325566-1325566
issn 2673-3153
2673-3153
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f4b4ffe024c84d85a4006b5847734e10
source PubMed Central
subjects antioxidant
assisted reproductive technology
oxidative stress
Reproductive Health
tocopherol nicotinate
varicocele
varicocelectomy
title Add-on effects of oral tocopherol supplementation to surgical varicocelectomy on the outcome of assisted reproductive technology: a single-center pilot study report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A51%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Add-on%20effects%20of%20oral%20tocopherol%20supplementation%20to%20surgical%20varicocelectomy%20on%20the%20outcome%20of%20assisted%20reproductive%20technology:%20a%20single-center%20pilot%20study%20report&rft.jtitle=Frontiers%20in%20reproductive%20health&rft.au=Takeshima,%20Teppei&rft.date=2024-01-22&rft.volume=5&rft.spage=1325566&rft.epage=1325566&rft.pages=1325566-1325566&rft.issn=2673-3153&rft.eissn=2673-3153&rft_id=info:doi/10.3389/frph.2023.1325566&rft_dat=%3Cproquest_doaj_%3E2922951721%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c418t-43999ec89ee5e9f67c22d6a151c27db7aff53ebef715c8e0c5ad93b2fe8fcd673%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2922951721&rft_id=info:pmid/38318605&rfr_iscdi=true